"We wanted to expand our global lab services in Europe, and looked for a well-established company with a reputation for quality and service and a culture that aligns with ours," says Wilson Hershey, Lancaster Laboratories president. "We found that company in Microchem, whose current services complement the pharmaceutical, biopharmaceutical, medical device, and environmental testing services we deliver to clients worldwide. This acquisition expands our ability to provide analytical services to our global clients, who operate internationally."
Lancaster Laboratories is part of the BioPharma Services Division of Thermo Fisher Scientific Inc. (NYSE: TMO). Thermo Fisher is the world leader in serving science, enabling its customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, the company employs 30,000 people and serves over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Visit www.thermofisher.com.
